RenovoRx Reports Q1 GAAP EPS -$0.32, Revenue $1.12M RenovoRx reported GAAP EPS -$0.32 and revenue $1.12M for Q1 2026, missing consensus by $0.18M (≈13.8%) on Mar 30, 2026 (Seeking Alpha).

RenovoRx Reports Q1 GAAP EPS -$0.32, Revenue $1.12M: RenovoRx reported GAAP EPS -$0.32 and revenue $1.12M for Q1 2026, missing consensus by $0.18M (≈13.8%) on Mar 30, 2026 (Seeking Alpha). 👈 Read full analysis #RenovoRx #EarningsReport #GAAPEPS #FinanceNews #InvestmentInsights

RenovoRx CFO Voll Acquires RNXT Shares and Warrants CFO Voll bought 47,000 RNXT shares and 94,000 warrants (Form 4 filed Mar 24, 2026); RNXT traded near $0.21, warrant strike $0.40 (Investing.com, SEC).

RenovoRx CFO Voll Acquires RNXT Shares and Warrants: CFO Voll bought 47,000 RNXT shares and 94,000 warrants (Form 4 filed Mar 24, 2026); RNXT traded near $0.21, warrant strike $0.40 (Investing.com, SEC). 👈 Read full analysis #RenovoRx #CFO #Stocks #Investing #RNXT